7 Signs of MASH Liver Disease That Can Be Easy to Miss

MASH liver disease, short for metabolic dysfunction-associated steatohepatitis, is a serious form of fatty liver disease linked with metabolic health problems. It happens when excess fat builds up in the liver and leads to inflammation, liver cell injury, and sometimes scarring. What makes MASH liver disease concerning is that it can be quiet for years, causing little or no discomfort while damage slowly develops. Many people only find out they have it after abnormal liver blood tests, imaging, or evaluation for diabetes, obesity, high cholesterol, or high blood pressure.

Recognizing early signs of MASH liver disease can help people seek care before the condition progresses to advanced fibrosis, cirrhosis, or liver failure. Fatigue, upper right abdominal discomfort, unexplained weakness, appetite changes, swelling, itchy skin, and yellowing of the skin or eyes may all appear as liver stress worsens. These signs can be easy to miss because they may feel vague or seem unrelated to the liver. This article explains seven signs of MASH liver disease that can be overlooked and why early medical evaluation matters.

What is MASH Liver Disease?

Metabolic dysfunction-associated steatohepatitis (MASH) is a severe and progressive form of liver disease characterized by the presence of excess fat in the liver (steatosis) combined with active inflammation and liver cell damage. This condition is a more aggressive subtype of the broader category known as Metabolic dysfunction-associated steatotic liver disease (MASLD).

To better understand this complex condition, it’s helpful to explore its components and how it fits within the spectrum of metabolic liver diseases. The progression from a relatively benign fatty liver to the more dangerous state of MASH is a critical distinction, as MASH is the stage that significantly elevates the risk of life-threatening complications like extensive scarring (fibrosis), cirrhosis, liver failure, and liver cancer. Its connection to systemic metabolic health means it often coexists with other major health issues like type 2 diabetes and cardiovascular disease, making its management a multifaceted challenge.

Deconstructing the Medical Term MASH

The medical term mash stands for Metabolic dysfunction-associated steatohepatitis. This terminology provides a precise description of the disease’s underlying causes and the specific physical damage occurring inside the organ, helping clarify the true mash liver meaning.

[Metabolic Dysfunction-Associated] ──► Driven by insulin resistance, type 2 diabetes, & obesity
[Steatohepatitis]                 ──► Steato (Fat accumulation >5%) + Hepatitis (Cell inflammation/injury)

Metabolic Dysfunction-Associated

This component highlights that m a s h disease is not rooted in excessive alcohol use. Instead, it is intrinsically linked to a cluster of systemic metabolic disorders. The primary drivers behind this mash liver condition include insulin resistance, abdominal obesity, type 2 diabetes, and dyslipidemia (unhealthy levels of cholesterol and triglycerides in the blood).

Steatohepatitis

This term describes the dual structural damage defining the disease:

• Steato-: Derived from the Greek word for fat, this refers to steatosis—the abnormal accumulation of triglycerides within liver cells (hepatocytes) until fat accounts for more than 5% of the liver’s total weight.

• -hepatitis: Combines hepa (liver) and itis (inflammation).

Together, they describe a dangerous state where chronic fat buildup triggers a continuous immune response, leading to the injury and death of vital liver cells.

The Steatotic Liver Disease Spectrum: MASLD vs. MASH

To truly understand this liver condition mash, it helps to look at its position within the broader spectrum of metabolic liver disorders. MASH liver disease is the progressive, inflammatory stage of an overarching umbrella condition called MASLD (Metabolic dysfunction-associated steatotic liver disease).

                     [The MASLD Spectrum Landscape]
                                   │
     ┌─────────────────────────────┴─────────────────────────────┐
     ▼                                                           ▼
[Simple Steatosis (MASLD End)]               [Active Steatohepatitis (MASH End)]
 ├── Passive fat buildup >5%                  ├── Lipotoxicity from excess fatty acids
 ├── Low inflammation or scarring             ├── Inflammatory immune cell infiltration
 └── Stable, lower clinical risk              └── Hepatocyte ballooning & progressive fibrosis

The transition across this spectrum represents a critical turning point in a patient’s long-term health:

• Simple Steatosis: This sits at the milder end of the MASLD spectrum. While the liver contains excess fat, there is minimal to no active inflammation or tissue injury. Simple fatty liver carries a lower risk of causing permanent organ damage if managed early.

• Active Steatohepatitis (MASH): This represents a severe escalation. The transition to a true mash illness occurs when the accumulated fat inside liver cells becomes toxic—a process known as lipotoxicity. This cellular stress causes liver cells to swell up and degrade in a pattern called “hepatocyte ballooning.” As these cells die, they release distress signals that trigger a chronic inflammatory response, prompting the liver to lay down rigid sheets of collagen (fibrosis).

Structural Damage Profiles: Progression to Cirrhosis

When a patient develops metabolic dysfunction associated steatohepatitis, the chronic cycle of cell death and immune activation alters the architecture of the organ. Over several years, the liver’s healing response creates permanent scar tissue.

[Fat Overload / Lipotoxicity] ──► Hepatocyte Ballooning ──► Collagen Fibrosis ──► Advanced Cirrhosis

As the mash fatty liver condition worsens, the continuous formation of scar tissue builds on itself:

1. Hepatocyte Ballooning: Overloaded liver cells swell dramatically, lose their normal structural shape, and eventually rupture.

2. Fibrosis Development: The immune system tries to repair this localized damage by producing collagen fibers. This initial scarring, known as fibrosis, starts around the blood vessels and liver lobules.

3. Advanced Cirrhosis: If the underlying metabolic triggers are not managed, the scar tissue can eventually overtake healthy liver tissue. This advanced stage, called cirrhosis, blocks normal blood flow through the organ, severely impairing liver function and significantly increasing the risk of liver failure and liver cancer (hepatocellular carcinoma).

Systemic Metabolic Comorbidities

A diagnosis of mash in liver disease is rarely an isolated medical issue. Because it is fundamentally rooted in metabolic dysfunction, this liver disease mash serves as a strong clinical indicator of broader systemic health challenges.

Understanding what causes mash in your liver requires looking at this interconnected web of metabolic issues. Because insulin resistance and lipid imbalances drive both arterial plaque buildup and liver tissue damage, treating mash disease effectively requires a comprehensive approach that addresses both metabolic health and liver function.

7 subtle symptoms of MASH Liver Disease that are easy to miss

The seven subtle symptoms of MASH Liver Disease that are easy to miss are profound fatigue, a dull ache in the upper right abdomen, persistent brain fog, spider angiomas on the skin, mild jaundice, edema in the legs, and unexplained weight loss or appetite changes.

Early Systemic Signifiers of Liver Duress

Because the liver possesses a massive reserve capacity, early to intermediate stages of mash liver disease often lack dramatic or overt indicators. Instead, the body emits quiet, systemic signals that are easily misattributed to common, everyday ailments. This allows the underlying mash illness to progress silently if these warnings are ignored.

[Chronic Liver Inflammation] ──► Cytokine Release ──► Central Nervous System Impact ──► Persistent Fatigue

Profound and Rest-Resistant Fatigue

Debilitating exhaustion that is not relieved by adequate rest is one of the most common yet frequently dismissed mash liver symptoms. The liver acts as the body’s primary metabolic engine, responsible for regulating blood sugar levels and converting nutrients into usable energy.

When the liver faces cellular stress from a mash fatty liver condition, its ability to manage glucose and lipids efficiently is compromised. Furthermore, the chronic tissue irritation releases a steady stream of inflammatory signaling molecules (cytokines) into the bloodstream. These chemicals directly affect the central nervous system, inducing a constant state of malaise and heavy fatigue.

Persistent Brain Fog (Minimal Hepatic Encephalopathy)

Declining liver function can lead to subtle cognitive deficits, such as difficulty concentrating, memory lapses, and mental sluggishness. This group of symptoms is an early manifestation of minimal hepatic encephalopathy.

A healthy liver continuously filters toxins from the bloodstream, converting ammonia (a byproduct of protein digestion) into urea so it can be safely excreted by the kidneys. When mash liver function drops, these neurotoxins can accumulate in the blood, cross the blood-brain barrier, and disrupt normal neurotransmitter function.

Localized Structural and Vascular Indicators

As inflammation and fat buildup continue to alter the architecture of the organ, physical signs can develop both within the abdomen and on the surface of the skin.

                      [Structural & Vascular Manifestations]
                                        │
     ┌──────────────────────────────────┴──────────────────────────────────┐
     ▼                                                                     ▼
[Capsular Tension (Abdominal Ache)]            [Vascular Dilation (Spider Angiomas)]
 ├── Fat & inflammation cause swelling          ├── Declining liver slows estrogen metabolism
 ├── Stretches the nerve-rich Glisson's capsule ├── Excess circulating hormones dilate arterioles
 └── Feels like a dull, localized fullness      └── Visible spider-like vessels on upper body

Dull Upper Right Quadrant Ache

While liver tissue itself does not contain nerve fibers that sense pain, the organ is encased in a thin, fibrous membrane called Glisson’s capsule, which is rich in nerve endings.

In patients with a mash liver condition, the combination of fat accumulation and tissue swelling causes the organ to enlarge (hepatomegaly). This swelling stretches the sensitive outer capsule, creating a dull, persistent ache or feeling of fullness in the upper right abdomen, just below the rib cage.

Spider Angiomas

The appearance of small, spider-like blood vessels on the skin—known as spider angiomas or spider nevi—is a visible sign of underlying liver disease. These lesions consist of a central red dot with fine blood vessels radiating outward. They typically appear on the face, neck, and upper chest.

When direct pressure is applied to the central dot, the vessel will temporarily blanch (turn white) and then rapidly refill from the center outward once released. This vascular change happens because an inflamed liver struggles to process hormones like estrogen. Elevated levels of estrogen circulate in the blood, causing the small blood vessels near the skin’s surface to dilate and become visible.

Advanced Markers of Hepatic Dysfunction

As the condition progresses toward more significant tissue scarring or advanced cirrhosis, the liver’s ability to process waste products and synthesize essential proteins begins to decline.

[Hepatocellular Damage]  ──► Impaired Bilirubin Clearance  ──► Tissue Deposition ──► Mild Jaundice
[Hypoalbuminemia State] ──► Dropping Oncotic Pressure    ──► Capillary Leakage ──► Pitting Edema

Mild Jaundice: A faint, sallow yellowing of the skin or, more noticeably, the whites of the eyes (sclera) is a classic sign of liver dysfunction. Jaundice occurs when a yellow-orange pigment called bilirubin builds up in the blood. Bilirubin is a normal waste product from the breakdown of old red blood cells. When liver cells are damaged by metabolic dysfunction associated steatohepatitis, they lose their ability to process and excrete bilirubin through bile, causing it to build up in bodily tissues.

Peripheral Pitting Edema: Unexplained fluid retention that causes swelling in the legs, ankles, and feet is a significant warning sign of worsening liver health. The liver is responsible for producing albumin, the most abundant protein in blood plasma, which helps maintain the pressure needed to keep fluid inside blood vessels. As chronic scarring compromises liver function, albumin production drops (hypoalbuminemia). This loss of pressure allows fluid to leak out of small capillaries and pool in the lower extremities due to gravity. Pressing a finger firmly against the swollen area leaves a temporary indentation in the skin, known as pitting.

Metabolic and Appetite Disruptions

The combination of ongoing liver tissue stress and systemic immune activation can cause noticeable changes in nutrition and body composition.

                     [Nutritional & Metabolic Changes]
                                     │
     ┌───────────────────────────────┴───────────────────────────────┐
     ▼                                                               ▼
[Appetite Suppression Pathways]                  [Nutritional Processing Failures]
 ├── Cytokines cross the blood-brain barrier     ├── Liver fails to synthesize calories effectively
 ├── Suppresses central hunger signaling mechanisms ├── Body enters a negative energy balance phase
 └── Complicated by mild, persistent nausea      └── Unintentional breakdown of muscle and fat

An unexplained loss of appetite accompanied by unintentional weight loss is a serious indicator of advancing mash liver disease. The liver plays a central role in digesting food and processing nutrients. When it is inflamed and malfunctioning, the body can no longer absorb or utilize calories efficiently.

Additionally, the chronic inflammation triggers the release of systemic cytokines, such as tumor necrosis factor-alpha (TNF-alpha). These chemicals can have an appetite-suppressing effect on the brain, reducing the desire to eat. This combination of poor nutrient processing and a lower appetite can force the body to break down its own muscle and fat stores, leading to unhealthy, unintentional weight loss.

Summary Matrix of Subtle MASH Symptoms

Understanding how do you know if you have mash liver disease requires looking at how these subtle clues interact, especially if you have existing risk factors like obesity, insulin resistance, or type 2 diabetes. Because early detection is key to managing the disease before permanent scarring develops, recognizing these quiet warnings is essential for securing a timely medical evaluation.

The primary causes and risk factors for MASH Liver Disease

The primary causes and risk factors for MASH Liver Disease are overwhelmingly rooted in metabolic dysfunction, driven principally by the cluster of conditions known as metabolic syndrome, which includes central obesity, insulin resistance or type 2 diabetes, high blood pressure, and dyslipidemia (abnormal blood fats). Unlike other liver diseases caused by viruses or alcohol, MASH is a direct consequence of the body’s disordered handling of fats and sugars.

This makes MASH a lifestyle-related disease for a large majority of patients. The modern environment, characterized by the widespread availability of high-calorie, processed foods and an increasingly sedentary existence, has fueled a global epidemic of obesity and type 2 diabetes. These conditions create a state of chronic metabolic stress that directly targets the liver. The liver becomes the repository for excess energy, storing it as fat, which eventually triggers the inflammation and damage that define MASH. Understanding these interconnected risk factors is essential for both prevention and management of the disease.

Is there a link between MASH and metabolic syndrome?

Yes, there is an exceptionally strong and direct link between MASH and metabolic syndrome; in fact, MASH is widely considered to be the hepatic (liver) manifestation of metabolic syndrome.

Metabolic syndrome is not a single disease but a cluster of at least three of the following five conditions: central or abdominal obesity (excess fat around the waist), high blood pressure (hypertension), high blood sugar levels (or a diagnosis of type 2 diabetes), high levels of triglycerides in the blood, and low levels of high-density lipoprotein (HDL), the “good” cholesterol. The presence of this syndrome indicates a state of profound metabolic dysregulation, with insulin resistance being a key underlying feature.

Each component of metabolic syndrome contributes directly to the development and progression of MASH. Central obesity leads to an overflow of free fatty acids from fat tissue into the liver. Insulin resistance forces the pancreas to produce more insulin, and high insulin levels signal the liver to ramp up its own production of fat (a process called de novo lipogenesis).

High triglycerides provide the raw materials for this fat accumulation in the liver. This cascade of events leads to steatosis (fatty liver), and the subsequent cellular stress and lipotoxicity ignite the inflammation and cell injury (hepatitis) that characterize MASH. The relationship is so strong that it’s estimated over 90% of patients with MASH also have metabolic syndrome, making it the single most important risk factor for the disease.

Can your diet and lifestyle lead to MASH Liver Disease?

Yes, diet and lifestyle are fundamental drivers of MASH Liver Disease, creating the metabolic conditions that allow the disease to develop and progress. The typical Western diet, high in calories, processed foods, saturated and trans fats, and, most critically, refined sugars like fructose, plays a direct role. Fructose, commonly found in sugary drinks and processed snacks as high-fructose corn syrup, is metabolized almost exclusively by the liver.

Consuming it in excess overwhelms the liver’s capacity and potently drives de novo lipogenesis—the creation of new fat—directly within the liver cells. This dietary pattern, combined with high intake of unhealthy fats and refined carbohydrates, provides a constant surplus of energy that the liver is forced to store as fat.

This harmful diet is often paired with a sedentary lifestyle, which further exacerbates the problem. Lack of physical activity worsens insulin resistance, meaning the body’s cells are less responsive to insulin, leading to higher blood sugar and insulin levels. Exercise helps muscles utilize glucose for energy, but without it, more of that energy is diverted to the liver for fat storage.

A sedentary lifestyle also promotes the accumulation of visceral fat—the dangerous fat stored around the abdominal organs—which is metabolically active and releases inflammatory substances that contribute to liver inflammation. The combination of a poor diet and physical inactivity creates a “perfect storm” for the development of obesity, insulin resistance, and ultimately MASH. Therefore, lifestyle modifications, including a healthy diet and regular exercise, are the cornerstone of both preventing and managing MASH.

How is MASH Liver Disease Diagnosed and Monitored?

MASH liver disease is diagnosed through a combination of blood tests, imaging studies, and sometimes a liver biopsy to assess fat, inflammation, and scarring. Furthermore, monitoring the disease involves regularly repeating these tests to track the progression of liver damage and the effectiveness of lifestyle interventions or treatments.

The Histological Stages of Liver Scarring (F0–F4)

The progression of mash liver disease is classified by the degree of fibrosis (scarring) within the tissue. This scarring develops as the liver attempts to heal itself from chronic inflammation and cell damage caused by fat buildup. To standardize these changes, clinicians use a staging scale ranging from F0 to F4.

[F0: No Scarring] ──► [F1: Mild Portal] ──► [F2: Moderate Extended] ──► [F3: Severe Bridging] ──► [F4: Cirrhosis]

• Stage F0 (No Fibrosis): The liver tissue maintains its normal structural architecture. While excess fat may be present within the cells (simple steatosis), no scar tissue has developed.

• Stage F1 (Mild Fibrosis): Small amounts of scar tissue appear. This scarring is minimal and remains confined to the portal areas—the small zones surrounding the liver’s primary blood vessels.

• Stage F2 (Moderate Fibrosis): The accumulation of scar tissue becomes more pronounced. At this stage, the scarring begins to extend outside the portal zones and into the surrounding healthy liver tissue.

• Stage F3 (Severe / Bridging Fibrosis): This stage represents a critical turning point in a mash diagnosis. The extensive bands of scar tissue form physical “bridges” that connect different portal and central areas of the liver, disrupting its internal structure and impairing normal blood flow.

• Stage F4 (Cirrhosis): The final and most severe stage of the disease. Normal liver architecture is replaced by widespread scar tissue and regenerative nodules. This advanced scarring is generally irreversible and significantly increases the risk of liver failure and liver cancer.

The Diagnostic Protocol: Labs, Imaging, and Tissue Biopsy

Confirming a diagnosis of metabolic dysfunction associated steatohepatitis requires a thorough evaluation to rule out other causes of liver injury and directly measure tissue damage.

                         [The Diagnostic Pipeline]
                                     │
     ┌───────────────────────────────┼───────────────────────────────┐
     ▼                               ▼                               ▼
[Biochemical Labs]             [Non-Invasive Elastography]     [Histological Biopsy]
 ├── Check ALT & AST enzymes    ├── Sound waves measure stiffness├── Confirm fat accumulation >5%
 ├── Identify tissue irritation ├── Quantify fibrosis stage     ├── Observe cell ballooning
 └── Rule out viral hepatitis   └── Track disease progression   └── Define definitive gold standard

Initial Laboratory and Standard Imaging Assessments

The diagnostic process typically begins with comprehensive blood tests, including liver function tests. Doctors look for elevated levels of key liver enzymes, specifically alanine aminotransferase (ALT) and aspartate aminotransferase (AST), which leak into the blood when liver cells are inflamed or damaged.

Next, standard imaging is ordered. An abdominal ultrasound is often the first tool used; it can identify steatosis (excess fat), which makes the liver tissue appear brighter or more echogenic than normal. However, a standard ultrasound cannot distinguish simple fatty liver from active liver disease mash, nor can it measure the exact amount of scar tissue.

Specialized Non-Invasive and Invasive Tools

• Transient Elastography (FibroScan): To measure scarring without an invasive procedure, specialists use non-invasive tools like a FibroScan. This device sends low-frequency sound waves through the liver to measure its physical stiffness. Because scar tissue is rigid, faster wave speeds correlate directly with more advanced stages of fibrosis.

• Liver Biopsy (The Gold Standard): While imaging offers helpful clues, a physical liver biopsy remains the definitive method to confirm MASH over other conditions.

During this quick outpatient procedure, a specialist uses a fine needle to guide a tiny sample of liver tissue out of the organ. A pathologist then examines the sample under a microscope to verify the three classic hallmarks of the disease:

1. Significant fat accumulation within the cells (steatosis)

2. Infiltration of inflammatory white blood cells

3. Clear evidence of liver cell damage and swelling (hepatocyte ballooning)

Structural Comparison: MASH vs. Alcohol-Related Liver Disease

While m a s h disease and alcohol-related liver disease (ALD) cause very similar patterns of tissue damage, they are driven by entirely different underlying causes.

[Metabolic Syndrome Drivers] ──► MASH ──► [Identical Under a Microscope] ──► ALD ──► [Excessive Alcohol Intake]

Under a microscope, the tissue damage from both conditions can look nearly identical, showing the same combination of fat buildup, cell ballooning, and progressive scarring. Because of this structural overlap, doctors must take a detailed patient history to rule out significant alcohol use before confirming a diagnosis of MASH.

The core difference lies in their origins: MASH is a metabolic condition driven by systemic issues like insulin resistance and diabetes in individuals who drink little to no alcohol. ALD, on the other hand, is caused directly by the toxic effects of chronic, excessive alcohol consumption on liver cells.

The “Lean MASH” Phenotype: Metabolic Issues Beyond BMI

A common misconception is that a person must be overweight or obese to develop a mash fatty liver. In reality, individuals with a body mass index (BMI) within the healthy range can still develop the condition—a presentation known as lean MASH.

[Healthy External BMI] ──► Visceral Adiposity Around Organs ──► Insulin Resistance ──► Lean MASH

[Image comparing subcutaneous fat under the skin with visceral fat stored deep around internal organs]

This presentation highlights that MASH is fundamentally a disease of metabolic dysfunction rather than simple body weight:

• Visceral Adiposity: Individuals with lean MASH often store fat deep inside the abdomen around their internal organs (visceral fat) rather than under the skin, meaning the fat buildup is not visible from the outside.

• Genetic Predispositions: Certain genetic variations can alter how the body processes, transports, and stores lipids, making some individuals prone to liver fat accumulation even with a normal weight.

• Hidden Metabolic Imbalances: Despite having a normal BMI, these individuals often show classic signs of metabolic syndrome, such as insulin resistance, high triglyceride levels, and elevated blood pressure. This serves as an important reminder that a healthy weight alone does not guarantee protection against metabolic liver disease.

Conclusion

MASH liver disease can be difficult to detect because many people have no symptoms in the early stages. When signs do appear, they may include tiredness, upper right abdominal pain, weakness, appetite loss, weight changes, itching, swelling, or jaundice. Since MASH can progress to liver scarring, cirrhosis, liver cancer, or liver failure, early diagnosis and risk-factor management are important. If you have metabolic risk factors or persistent symptoms that may suggest liver disease, a healthcare provider can recommend blood tests, imaging, fibrosis assessment, or specialist care.

Read more: 8 Causes of Bladder Inflammation Symptoms and What They May Reveal

Frequently Asked Questions

1. What is MASH liver disease?

MASH liver disease stands for metabolic dysfunction-associated steatohepatitis. It is a more serious form of fatty liver disease in which fat buildup causes liver inflammation and cell damage. Over time, this inflammation can lead to fibrosis, cirrhosis, or other liver complications. MASH was previously known as NASH, or nonalcoholic steatohepatitis.

2. What are common signs of MASH liver disease?

Many people with MASH liver disease have no symptoms at first. When symptoms occur, they may include fatigue, weakness, discomfort in the upper right abdomen, poor appetite, or unexplained weight changes. More advanced liver disease may cause itching, swelling in the legs or abdomen, dark urine, pale stools, or yellowing of the skin and eyes. These symptoms should be evaluated because they may suggest worsening liver function.

3. Who is at risk for MASH liver disease?

People with obesity, type 2 diabetes, insulin resistance, high cholesterol, high triglycerides, or high blood pressure have a higher risk of MASH liver disease. The condition is strongly linked with metabolic dysfunction rather than heavy alcohol use. Some people with a normal body weight can still develop fatty liver disease, especially if they have metabolic risk factors. Family history, diet, physical inactivity, and certain health conditions may also contribute.

4. How is MASH liver disease diagnosed?

Doctors may use blood tests, imaging tests, fibrosis tests, and sometimes liver biopsy to diagnose MASH liver disease. Blood tests can show liver enzyme changes, but normal liver enzymes do not always rule it out. Imaging may detect liver fat or scarring, while elastography can estimate liver stiffness. A liver biopsy may be used when doctors need to confirm inflammation, damage, or fibrosis severity.

5. How is MASH liver disease treated?

Treatment for MASH liver disease often begins with weight management, healthier eating, physical activity, and control of diabetes, cholesterol, and blood pressure. Reducing liver fat and inflammation can help slow or improve disease progression. Some patients with moderate to advanced liver scarring may be candidates for newer medicines under medical guidance. People with cirrhosis or advanced complications may need specialist monitoring and, in severe cases, liver transplant evaluation.

Sources

• Metabolic Dysfunction-Associated Steatohepatitis (MASH) (Cleveland Clinic)
• Nonalcoholic Fatty Liver Disease (NAFLD) & NASH (NIDDK)
• MASH Symptoms: Understanding Liver Health (American Liver Foundation)
• Fatty Liver Disease (MASLD) – Symptoms and Causes (Mayo Clinic)
• Fatty Liver Disease (MASLD) – Diagnosis and Treatment (Mayo Clinic)
• MASLD (Nonalcoholic Fatty Liver Disease) (Cleveland Clinic)
• Symptoms & Causes of Cirrhosis (NIDDK)
• Definition & Facts of NAFLD & NASH (NIDDK)